HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Breathe Right Snore Relief Throat Spray TV Ads Aimed At Boosting U.S. Sales

This article was originally published in The Tan Sheet

Executive Summary

CNS will launch a television advertising campaign in October for its Breathe Right Snore Relief Throat Spray

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

Sales & Earnings In Brief

McNeil Q2 sales: Second quarter U.S. sales growth of 19% in OTC unit fueled by increased promotional activities for adult Tylenol, pediatric Motrin brands, J&J says during July 16 analysts call. McNeil domestic sales reached $359 mil. in the period, offsetting a 7% decline in international sales to $65 mil. Worldwide revenues for women's health products up 5% to $321 mil. in the quarter, contributing to 7.8% global sales advance to $1.65 bil. for the overall J&J Consumer segment, which includes skin care and baby care products in addition to McNeil and women's health. Also contributing to the gain wereNeutrogena, Clean & Clear skin care products, Viactiv chewable calcium supplements, J&J notes...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts